Search

Search Constraints

You searched for: Author/Creator Lievens, Marc

Search Results

1. 119. Safety and Reactogenicity of an Investigational Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine for Adults ≥ 60 Years of Age (RSVPreF3 OA): an Interim Analysis at 6 Months after Vaccination. (15th December 2022)

2. 96. A Candidate Respiratory Syncytial Virus (RSV) Prefusion F Protein Investigational Vaccine (RSVPreF3 OA) Is Immunogenic when Administered in Adults ≥ 60 Years of Age: Results at 6 Months after Vaccination. (15th December 2022)

3. A Phase IIa Controlled Human Malaria Infection and Immunogenicity Study of RTS, S/AS01E and RTS, S/AS01B Delayed Fractional Dose Regimens in Malaria-Naive Adults. (20th July 2020)

4. A phase IIA extension study evaluating the effect of booster vaccination with a fractional dose of RTS, S/AS01E in a controlled human malaria infection challenge. Issue 43 (15th October 2021)

5. Efficacy of RTS, S/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5–17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial. Issue 9 (September 2022)

6. Immune response to the hepatitis B antigen in the RTS, S/AS01 malaria vaccine, and co-administration with pneumococcal conjugate and rotavirus vaccines in African children: A randomized controlled trial. Issue 6 (3rd June 2018)

7. Immunogenicity and safety of the RTS, S/AS01 malaria vaccine co-administered with measles, rubella and yellow fever vaccines in Ghanaian children: A phase IIIb, multi-center, non-inferiority, randomized, open, controlled trial. Issue 18 (16th April 2020)

8. Long-term immunogenicity and immune memory response to the hepatitis B antigen in the RTS, S/AS01E malaria vaccine in African children: a randomized trial. Issue 6 (2nd June 2020)

9. Long-term incidence of severe malaria following RTS, S/AS01 vaccination in children and infants in Africa: an open-label 3-year extension study of a phase 3 randomised controlled trial. Issue 8 (August 2019)

10. Safety and efficacy of novel malaria vaccine regimens of RTS, S/AS01B alone, or with concomitant ChAd63-MVA-vectored vaccines expressing ME-TRAP. (December 2018)